Cognitive Impairment in Neurodegenerative Movement Disorders
Carla Abdelnour1, Kathleen L Poston1,2
1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California.
Seminars in Neurology
|March 20, 2023
Summary
Cognitive impairment is common in neurodegenerative movement disorders, impacting quality of life. This review guides neurologists in assessing and managing these cognitive symptoms in patients with conditions like Parkinson's disease.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Cognitive impairment frequently complicates neurodegenerative movement disorders, significantly affecting patient quality of life, caregiver burden, and institutionalization rates.
- Understanding and addressing cognitive symptoms is crucial for comprehensive patient care, including accurate diagnosis, effective management, and prognosis.
- Cognitive dysfunction is a critical aspect of neurodegenerative movement disorders that requires focused clinical attention.
Approach:
- This review synthesizes current knowledge on the cognitive impairment profiles associated with common movement disorders.
- It examines specific conditions including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome, and Huntington's disease.
- The review offers practical evaluation tools and management strategies for neurologists.
Key Points:
- Each movement disorder presents a distinct cognitive impairment profile.
- Early and accurate assessment of cognitive function is vital for tailored patient management.
- Neurologists can utilize provided guidance and tools for effective patient and caregiver support.
- Cognitive symptoms significantly influence the trajectory and management of neurodegenerative movement disorders.
Conclusions:
- Effective management of neurodegenerative movement disorders necessitates a thorough understanding of associated cognitive impairments.
- This review provides a framework for neurologists to assess and manage cognitive deficits, improving patient outcomes.
- Addressing cognitive symptoms is integral to holistic care for patients with movement disorders and their families.
Related Concept Videos
01:15Parkinson's Disease: Overview
634
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
634
01:26Alzheimer's Disease: Overview
562
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
562
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
173
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
173
01:28Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
01:14Role of Cerebellum and Prefrontal Cortex in Memory
522
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
522
01:30Dementia
150
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
150